Symptomtext
This case involves a 1 years old male patient who experienced when nurse gave injection it dripped down the patient's leg with no reported adverse event while receiving vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] and while treated with PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) [PREVNAR]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included INFLUENZA VACCINE (INFLUENZA VACCINE) for Prophylactic vaccination. On 15-Dec-2021, the patient started taking PREVNAR (PNEUMOCOCCAL VACCINE CONJ 7V (CRM197)) Unknown dosage unknown intramuscular (with an unknown batch number) for Prophylactic vaccination. On 15-Dec-2021, the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5)/HIB (PRP/T) VACCINE lot UJ570AAA via intramuscular route in left leg for Prophylactic vaccination. On 15-Dec-2021, the patient developed a non-serious event, "when nurse gave injection it dripped down the patient's leg with no reported adverse event" (incorrect dose administered) (same day latency).It was reported, " when nurse gave injection it dripped down the patient's leg. She asks for appropriate follow-up. She is not sure which vaccine, Prevnar or Pentacel, was the one that dripped" Action taken with DIPHTHERIA, TETANUS, AC PERTUSSIS, IPV AND HIB VACCINE (PENTACEL) and PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) was not applicable. It was not reported if the patient received a corrective treatment for the event (when nurse gave injection it dripped down the patient's leg with no reported adverse event). At time of reporting, the outcome was Unknown for the event when nurse gave injection it dripped down the patient's leg with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.